WAM
COLL icon

Watershed Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Watershed Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$542K Buy
14,970
+1,392
+10% +$47.6K 0.48% 50
2026
Q1 		$449K Buy
13,578
+3,955
+41% +$167K 0.47% 57
2025
Q4 		$446K Buy
+9,623
New +$403K 0.42% 57
2023
Q4 		$294K Sell
9,546
-1,348
-12% -$33.8K 0.34% 62
2023
Q3 		$243K Sell
10,894
-120
-1% -$2.74K 0.29% 107
2023
Q2 		$237K Buy
+11,014
New +$250K 0.29% 98

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Watershed Asset Management's COLL Position: Q2 2026 in Review

Watershed Asset Management increased its Collegium Pharmaceutical (COLL) stake by 10% in Q2 2026, buying an estimated $47.6K and bringing the position to 14,970 shares worth $542K. The position accounts for 0.48% of the portfolio, ranked #50.

Watershed Asset Management first reported a position in COLL in Q2 2023 and has held it in 6 quarters since. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Watershed Asset Management held 14,970 shares of Collegium Pharmaceutical worth $542K as of Q2 2026.
  • Watershed Asset Management bought 1,392 Collegium Pharmaceutical shares in Q2 2026, an estimated $47.6K.
  • Collegium Pharmaceutical made up 0.48% of Watershed Asset Management's portfolio in Q2 2026, its #50 holding.
  • Watershed Asset Management first reported a position in Collegium Pharmaceutical in Q2 2023 and has held it in 6 quarters since.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Watershed Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.